Dr. Sikander Ailawadhi is an Associate Professor with the Division of Hematology-Oncology at Mayo Clinic in Jacksonville, Florida. He joined the Division in 2014 when he moved from the University of Southern California, Los Angeles, where he was an academic faculty with Hematology.

Dr. Ailawadhi’s career focus has been on treatment of plasma cell disorders, namely multiple myeloma and Waldenström’s macroglobulinemia. His research has focused on understanding the epidemiology and pathophysiology of these disorders, evaluating the benefit of various therapeutic strategies in different populations based on racial-ethnic and socioeconomic diversity, as well as developing novel therapeutics by means of conducting several regional and national clinical trials. Some of these research projects have included comparison of various epidemiological and disease-related characteristics in patients with multiple myeloma, Waldenström’s macroglobulinemia and chronic lymphocytic leukemia in various ethnic subgroups of the population, exploring molecular variations in multiple myeloma patients from different age groups and ethnic backgrounds, patient knowledge, compliance and psychosocial distress analyses in hematological malignancies, investigator-initiated and cooperative group clinical trials of novel therapeutic regimens in patients with these diagnoses, and secondary analyses of large databases (eg, SEER, SEER-Medicare and NCDB) to understand practice patterns and outcomes across United States.